(May 2014) A drug for hepatitis C, currently in clinical trials at the
University of Colorado Hospital, was hailed in March as a cure for
patients who previously have had to endure debilitating treatments.
word is cure. To me, the cure of hep C is one of the most significant
medical developments of the last 50 years,” says Greg Everson, MD,
professor of medicine and director of the section of hepatology. “We’ve
been able to cure hep C since the early 1990s, but the older drug
combinations had a much lower success rate. Sovaldi is the new backbone
The drug, Sovaldi, is a daily dose pill that has cured
about 90 percent of patients in 12 weeks when used with older drugs.
Previously, patients took other pills and injections for up to a year
and suffered from severe side effects.